Haemostatix

Developing new class of peptide based coagulant

placeNottingham, England, United Kingdom calendar_todayFounded 2003 groups11,995 employees language haemostatix.com

Registered entities

Innovation

10 patent families (7 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 473 times.

YearFilings
20134
20145
20157
20165
20175
20185
20193
20204
20214
20223
20231
20241

Investor mix

12 investors on record; lead investors include Catapult Ventures, Spark Ventures, Leicester, Albion Capital Group.

Investor typeCountShare
Venture capital758%
Accelerator & incubator18%
Other / undisclosed433%
Coming soon